Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2011
11/03/2011US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011US20110268723 CCR3 Inhibition for Ocular Angiogenesis and Macular Degeneration
11/03/2011US20110268722 Combination therapies with mitochondrial-targeted anti-tumor agents
11/03/2011US20110268699 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
11/03/2011US20110268695 Use of hmgb fragments as anti-inflammatory agents
11/03/2011US20110268679 Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
11/03/2011US20110268670 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2011US20110268657 Compositions and methods for the treatment of tumor of hematopoietic origin
11/03/2011US20110268656 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
11/03/2011US20110268655 Anti-alpha v immunoliposome compositions, methods and uses
11/03/2011US20110268653 Compositions and Methods Related to Acid Stable Lipid Nanospheres
11/03/2011CA2803254A1 Slit and roundabount (robo) mediated lymph vessel formation and uses thereof
11/03/2011CA2795799A1 Anti-erbb3 antibodies
11/03/2011CA2795544A1 Combination therapy of an afucosylated cd20 antibody with a mtor inhibitor
11/02/2011EP2383343A2 Recombinant varicella-zoster virus
11/02/2011EP2383342A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011EP2383295A1 IP-10 antibodies and their uses
11/02/2011EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
11/02/2011EP2383288A2 Differential in tumour gene products and use of same
11/02/2011EP2383285A2 Peptide Sequences and Compositions
11/02/2011EP2383284A2 Peptide sequences and compositions
11/02/2011EP2382991A1 Methods for treating conditions associated with MASP-2 dependent complement activation
11/02/2011EP2382990A1 Methods for treating cancer using an immunotoxin
11/02/2011EP2382989A1 Method for preparing recombinant antigen complex using rotavirus nanoparticle
11/02/2011EP2382988A1 Combined mucosal and parenteral immunization against HIV
11/02/2011EP2382987A1 Storage of influenza vaccines without refrigeration
11/02/2011EP2382986A2 Vaccine against streptococcus pneumoniae
11/02/2011EP2382985A1 Recombinant avian-infectious coryza vaccine and method for producing same
11/02/2011EP2382316A1 A recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
11/02/2011EP2382314A1 C1orf59 peptides and vaccines including the same
11/02/2011EP2382307A2 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.
11/02/2011EP2381960A1 Stable pharmaceutical composition containing at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents
11/02/2011EP2381959A1 Stable vaccine compositions and methods of use
11/02/2011EP2381958A1 Potato virus a coat protein-based vaccine for treating melanoma and its use
11/02/2011EP2381949A1 Immunostimulating saponins for use in in situ tumor-destruction therapy
11/02/2011EP2381934A2 Improving cognitive function
11/02/2011EP2381920A2 Methods and compositions for treating p.acnes
11/02/2011EP2381788A2 Targeted cryptosporidium biocides
11/02/2011EP2351581A9 A vaccine composition against foot-and-mouth disease and the preparation method thereof
11/02/2011EP2051710B1 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
11/02/2011EP1843787B1 Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines
11/02/2011EP1836225B1 Kir-binding agents and methods of use thereof
11/02/2011EP1827437B1 Combinations of therapeutic agents for treating cancer
11/02/2011EP1756143B1 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
11/02/2011EP1755659B1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
11/02/2011EP1730194B1 Bi-specific antibodies for targeting cells involved in allergic-type reactions, compositions and uses thereof
11/02/2011EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
11/02/2011EP1572746B1 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
11/02/2011EP1508043B1 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl
11/02/2011EP1501542B2 Improved polysaccharide and glycoconjugate vaccines
11/02/2011EP1425389B1 Human antibodies specific for interleukin 15 (il-15)
11/02/2011EP1386165B1 Inflammatory markers for detection and prevention of diabetes mellitus
11/02/2011EP1311290B1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
11/02/2011EP1299522B1 Alteration of cell membrane
11/02/2011EP1212359B1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
11/02/2011EP1036180B2 Vaccine prepared with circovirus type b sequences related to piglet weight loss disease (pwd)
11/02/2011CN1759121B Purification process for bacterial cytolysin
11/02/2011CN1753912B Antibodies against PD-1 and uses therefor
11/02/2011CN1629185B Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011CN102232115A Methods and compositions for diagnosing and treating a colorectal adenocarcinoma
11/02/2011CN102232088A Anti-PCSK9 and methods for treating lipid and cholesterol disorders
11/02/2011CN102232086A Process for the modulation of the antagonistic activity of a monoclonal antibody
11/02/2011CN102232083A 禽流感疫苗 Bird flu vaccine
11/02/2011CN102229916A Chicken Flavivirus and inactivated vaccine thereof
11/02/2011CN102229915A EV71 virus monoclonal antibody, hybridoma cell line and application
11/02/2011CN102229671A Anti-IMMT anthropogenic Fab antibody and application thereof in preparing anti-liver cancer drugs
11/02/2011CN102229660A Truncated human papillomavirus 33 type L1 protein
11/02/2011CN102229651A Amyloid protein intra-membrane segment for treating Alzheimer disease and application thereof
11/02/2011CN102229648A HLA-A*0201 restrictive CTL (cytotoxic T lymphocyte) epitope for tumor antigen Pokemon and application thereof
11/02/2011CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/02/2011CN102228698A HPV58 (Human Papilloma Virus) type therapeutic composite genetic vaccine and construction method thereof
11/02/2011CN102228688A OmpC-HBsAg (Outer membrane protein Complex-Hepatitis B surface Antigen) 'a' chimeric epitope therapeutic vaccine for hepatitis B
11/02/2011CN102228687A Freeze-dried live attenuated hepatitis A vaccine not containing gelatin or human albumin protective agent and preparation method for freeze-dried live attenuated hepatitis A vaccine
11/02/2011CN102228686A Process for preparing veterinary rabies inactivated and freeze-dried vaccine through suspension culture cell
11/02/2011CN102228685A Preparation method of iridovirus cell inactivated vaccine for Chinese giant salamanders, and application method thereof
11/02/2011CN102228482A Propolis injection for preventing duck hemorrhagic oophoritis and preparation method thereof
11/02/2011CN102228481A Propolis injection for preventing type I duck virus hepatitis and preparation method thereof
11/02/2011CN101531718B Anti-VEGFR-2 antibody chimeric Fab antibody fragment, preparation method and application thereof
11/01/2011US8049001 Probe, probe set, probe carrier, and testing method
11/01/2011US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011US8048985 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule
11/01/2011US8048918 Treatment of hyperproliferative diseases
11/01/2011US8048858 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions
11/01/2011US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011US8048844 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2011US8048434 Mycobacterium W and/or its constituents; nonpathogenic, cultivable
11/01/2011US8048433 whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica
11/01/2011US8048432 Polysaccharide-protein conjugate vaccines
11/01/2011US8048431 Modified HIV-1 clade C envelope glycoprotein immunogens comprising deletions in the gp120/gp41 cleavage site and gp41 fusion domain
11/01/2011US8048430 Influenza hemagglutinin and neuraminidase variants
11/01/2011US8048429 Inactivated chimeric flavivirus
11/01/2011US8048428 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
11/01/2011US8048427 Subgenomic replicons of the flavivirus dengue
11/01/2011US8048425 modified to be cytotoxic by altering its amino acid sequence so that it is not bound easily by the ribonuclease inhibitor while still retaining catalytic properties
11/01/2011US8048424 Insect poison allergens with reduced IgE reactivity and method for producing the same
11/01/2011US8048423 Treating warts, corns, bunions, ulcers, calluses, neuromas, ulcers, and hammertoes; reducing pain, size of the skin disorder, or inflammation
11/01/2011US8048422 Tweak binding antibodies
11/01/2011US8048421 Agonist antibody to human thrombopoietin receptor
11/01/2011US8048420 Monoclonal antibody